These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1385534)

  • 21. A recombinant single-chain human class II MHC molecule (HLA-DR1) as a covalently linked heterotrimer of alpha chain, beta chain, and antigenic peptide, with immunogenicity in vitro and reduced affinity for bacterial superantigens.
    Zhu X; Bavari S; Ulrich R; Sadegh-Nasseri S; Ferrone S; McHugh L; Mage M
    Eur J Immunol; 1997 Aug; 27(8):1933-41. PubMed ID: 9295029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel methods to rapidly and sensitively analyze antigenic peptide binding to MHC class II molecules.
    Nag B; Deshpande SV; Clark BR
    J Immunol Methods; 1991 Aug; 142(1):105-11. PubMed ID: 1717592
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunomodulation of experimental autoimmune encephalomyelitis with ordered peptides based on MHC-TCR binding motifs.
    Ruiz PJ; DeVoss JJ; Nguyen LV; Fontoura PP; Hirschberg DL; Mitchell DJ; Garcia KC; Steinman L
    J Immunol; 2001 Sep; 167(5):2688-93. PubMed ID: 11509612
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Visualization of myelin basic protein (MBP) T cell epitopes in multiple sclerosis lesions using a monoclonal antibody specific for the human histocompatibility leukocyte antigen (HLA)-DR2-MBP 85-99 complex.
    Krogsgaard M; Wucherpfennig KW; Cannella B; Hansen BE; Svejgaard A; Pyrdol J; Ditzel H; Raine C; Engberg J; Fugger L
    J Exp Med; 2000 Apr; 191(8):1395-412. PubMed ID: 10770805
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HLA-DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides.
    Riberdy JM; Newcomb JR; Surman MJ; Barbosa JA; Cresswell P
    Nature; 1992 Dec; 360(6403):474-7. PubMed ID: 1448172
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recognition of core and flanking amino acids of MHC class II-bound peptides by the T cell receptor.
    Sant'Angelo DB; Robinson E; Janeway CA; Denzin LK
    Eur J Immunol; 2002 Sep; 32(9):2510-20. PubMed ID: 12207335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Invariant chain peptides enhancing or inhibiting the presentation of antigenic peptides by major histocompatibility complex class II molecules.
    Adams S; Humphreys RE
    Eur J Immunol; 1995 Jun; 25(6):1693-702. PubMed ID: 7614997
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro maximum binding of antigenic peptides to murine MHC class II molecules does not always take place at the acidic pH of the in vivo endosomal compartment.
    Nag B; Passmore D; Deshpande SV; Clark BR
    J Immunol; 1992 Jan; 148(2):369-72. PubMed ID: 1370312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HLA-DM induces CLIP dissociation from MHC class II alpha beta dimers and facilitates peptide loading.
    Denzin LK; Cresswell P
    Cell; 1995 Jul; 82(1):155-65. PubMed ID: 7606781
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Direct binding of myelin basic protein and synthetic copolymer 1 to class II major histocompatibility complex molecules on living antigen-presenting cells--specificity and promiscuity.
    Fridkis-Hareli M; Teitelbaum D; Gurevich E; Pecht I; Brautbar C; Kwon OJ; Brenner T; Arnon R; Sela M
    Proc Natl Acad Sci U S A; 1994 May; 91(11):4872-6. PubMed ID: 7515181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Crystal structure of a superantigen bound to the high-affinity, zinc-dependent site on MHC class II.
    Li Y; Li H; Dimasi N; McCormick JK; Martin R; Schuck P; Schlievert PM; Mariuzza RA
    Immunity; 2001 Jan; 14(1):93-104. PubMed ID: 11163233
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HLA-DR4-IE chimeric class II transgenic, murine class II-deficient mice are susceptible to experimental allergic encephalomyelitis.
    Ito K; Bian HJ; Molina M; Han J; Magram J; Saar E; Belunis C; Bolin DR; Arceo R; Campbell R; Falcioni F; Vidović D; Hammer J; Nagy ZA
    J Exp Med; 1996 Jun; 183(6):2635-44. PubMed ID: 8676084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Promiscuous binding of proinsulin peptides to Type 1 diabetes-permissive and -protective HLA class II molecules.
    Astill TP; Ellis RJ; Arif S; Tree TI; Peakman M
    Diabetologia; 2003 Apr; 46(4):496-503. PubMed ID: 12684749
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two distinct class II molecules encoded by the genes within HLA-DR subregion of HLA-Dw2 and Dw12 can act as stimulating and restriction molecules.
    Sone T; Tsukamoto K; Hirayama K; Nishimura Y; Takenouchi T; Aizawa M; Sasazuki T
    J Immunol; 1985 Aug; 135(2):1288-98. PubMed ID: 3159789
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peptide motif for the rat MHC class II molecule RT1.Da: similarities to the multiple sclerosis-associated HLA-DRB1*1501 molecule.
    Duyar H; Dengjel J; de Graaf KL; Wiesmüller KH; Stevanović S; Weissert R
    Immunogenetics; 2005 Apr; 57(1-2):69-76. PubMed ID: 15711804
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence for invariant chain 85-101 (CLIP) binding in the antigen binding site of MHC class II molecules.
    Bangia N; Watts TH
    Int Immunol; 1995 Oct; 7(10):1585-91. PubMed ID: 8562503
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural requirements for binding of myelin basic protein (MBP) peptides to MHC II: effects on immune regulation.
    Mantzourani ED; Mavromoustakos TM; Platts JA; Matsoukas JM; Tselios TV
    Curr Med Chem; 2005; 12(13):1521-35. PubMed ID: 15974985
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative analysis of peptides from myelin basic protein binding to the MHC class II protein, I-Au, which confers susceptibility to experimental allergic encephalomyelitis.
    Fugger L; Liang J; Gautam A; Rothbard JB; McDevitt HO
    Mol Med; 1996 Mar; 2(2):181-8. PubMed ID: 8726461
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of binding domains on the superantigen, toxic shock syndrome-1, for class II MHC molecules.
    Soos JM; Russell JK; Jarpe MA; Pontzer CH; Johnson HM
    Biochem Biophys Res Commun; 1993 Mar; 191(3):1211-7. PubMed ID: 8466498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Short-lived complexes between myelin basic protein peptides and IAk.
    Mason K; McConnell HM
    Proc Natl Acad Sci U S A; 1994 Dec; 91(26):12463-6. PubMed ID: 7528922
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.